A report just released by the Commissioner of the Food & Drug Administration (FDA), Dr. Margaret Hamburg, aims to provide immediate steps to quicken biomedical innovation.
Entitled “Driving Biomedical Innovation: Initiatives to Improve Products for Patients,” the 37-page blueprint briefly touches upon a number of important topics, including how to build the infrastructure to drive and support personalized medicine as well as what the FDA anticipates to be the future of medical devices (e.g. in terms of regulation).
According to the FDA press release, the blueprint focuses on:
• rebuilding FDA’s small business outreach services
• building the infrastructure to drive and support personalized medicine
• creating a rapid drug development pathway for important targeted therapies
• harnessing the potential of data mining and information sharing while protecting patient privacy
• improving consistency and clarity in the medical device review process
• training the next generation of innovators
• streamlining and reforming FDA regulations.
To access the full report, please visit the FDA report page. It is worth the quick read, though hopefully more details about each of these topics will come out soon.
Press release: FDA commissioner outlines steps to spur biomedical innovation, improve health of Americans
